‌

US Patent 11686731 Prostate cancer markers and uses thereof

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

June 27, 2023

0

Patent Application Number

155402950

Date Filed

January 5, 2016

0

Patent Citations

US Patent 8790647 Treatment of vasculoproliferative conditions with Lrg1 anatgonists

0

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to LRG1 protein markers for use in the diagnosis, prognosis, and determination of treatment of prostate cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11686731 Prostate cancer markers and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.